Ascendis Pharma A/S reports results for the quarter ended in June - Earnings Summary

Ascendis Pharma A/S

25/08/2021 22:30

* Ascendis Pharma A/S  ASND.OQ  reported a quarterly adjusted
loss of €2.50​​ per share for the quarter ended in June. The
mean expectation of nine analysts for the quarter was for a loss
of €2.23 per share.
* Revenue fell 28.8% to €1.02 million from a year ago;  analysts
expected €845.50 thousand. 
* Ascendis Pharma A/S's reported EPS for the quarter was a loss
of €2.50​.
* The mean earnings estimate of analysts had fallen by
about 18.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Ascendis Pharma A/S shares had fallen by 7.4% this quarter and
lost 27.0% so far this year.
* The company reported a quarterly loss of €134.37 million.
* Wall Street's median 12-month price target for Ascendis Pharma
A/S is $190.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 25 at 09:29 p.m.  ​All
figures in euros unless otherwise stated